Elsevier

The Lancet

Volume 345, Issue 8953, 1 April 1995, Pages 820-824
The Lancet

HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy

https://doi.org/10.1016/S0140-6736(95)92963-0Get rights and content

Abstract

The response of HIV-1 to initial zidovudine (ZDV) treatment was assessed in 11 patients with severe HIV disease. We quantified serum HIV-1 concentrations and mutations associated with ZDV resistance by culture-independent methods. There was a prompt fall in serum HIV-1 RNA within 1-2 days of treatment with maximum suppression by seven days, which was paralleled by changes in serum p24 antigen (p24 Ag). Serum RNA started to return to pre-treatment levels within weeks. The HIV reverse transcriptase (RT) gene in most patients developed mutations associated with drug resistance within months and as early as 25 days on therapy in one patient. The codon changes were not sufficient to explain the early return of serum HIV-1 RNA levels and their patterns continued to evolve after patients stopped taking Z DV. The significance of these findings is discussed in relation to the limited long-term efficacy of ZDV. The dynamic time course of viral load and RT responses to ZDV is of particular importance in short-term interventions such as pregnancy.

References (33)

  • R. Yarchoan et al.

    Administration of 3' azido-3'-deoxythymidine, an inhibitor of HTLVIII/LAV replication, to patients with AIDS or AIDS-related complex

    Lancet

    (1986)
  • C. Loveday et al.

    Enzyme linked immunosorbent assays for the measurement of human immunodeficiency virus type 1, reverse transcriptase antigen and antibodies.

    J Virol Meth

    (1993)
  • H. Mitsuya et al.

    3' Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity of cytopathic effect of human T-lymphotropic virus type III/lympadenopathy-associated virus in vitro

    Proc Natl Acad Sci USA

    (1985)
  • Dd Ho et al.

    Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

    N Engl J Med

    (1989)
  • Rw Coombs et al.

    Plasma viraemia in human immunodeficiency virus infection

    N Engl J Med

    (1989)
  • Ma Fischl et al.

    The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial

    N Engl J Med

    (1987)
  • Ma Fischl et al.

    The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind, placebo-controlled trial

    Ann Intern Med

    (1990)
  • Pa Furman et al.

    Phosphorylation of 3' azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virius reverse transcriptase

    Proc Natl Acad Sci USA

    (1986)
  • R. Yarchoan et al.

    Development of anti-retroviral therapy for acquired immunodeficiency syndrome and related disorders

    N Engl J Med

    (1987)
  • Ba Larder et al.

    HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

    Science

    (1989)
  • P. Kellam et al.

    Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high level resistance to zidovudine

    Proc Natl Acad Sci USA

    (1992)
  • Ba Larder et al.

    Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine

    Science

    (1989)
  • Concorde-coordinating Committee

    Concorde: MRC/ARNS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection

    Lancet

    (1994)
  • Em Connor et al.

    Reduction of maternal- infant transmission of human immunodeficiency virus type 1 with zidovudine treatment

    N Engl J Med

    (1994)
  • Zidovudine for mother, fetus and child: hope or poison?

    Lancet

    (1994)
  • Centres for Disease Control

    Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome

    MMWR

    (1987)
  • Cited by (91)

    • The Genetic Diversity and Global Molecular Epidemiology of HIV

      2004, AIDS and Other Manifestations of HIV Infection
    • HIV-1 genotypic and phenotypic resistance

      2002, Clinics in Laboratory Medicine
    • Testing for HIV-1 drug resistance

      2001, Molecular Diagnosis
    • A solid phase plate assay for HIV-1 genotyping

      2000, Molecular and Cellular Probes
    View all citing articles on Scopus
    View full text